Alicia J. Sacco, PharmD, BCCCP, FCCM: No relevant financial relationship(s) to disclose.
The role of vasopressor therapy in refractory shock management will be discussed. This will include a review of the available agents as well as analysis of available literature to further elucidate agent selection and application to specific patient populations.